Bortezomib suppresses acute myelogenous leukaemia stem‐like KG ‐1a cells via NF‐κB inhibition and the induction of oxidative stress
Journal of Cellular and Molecular Medicine · 2024
DOI: 10.1111/jcmm.18333 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Cellular and Molecular Medicine, 2024. Verfasst von Rafaela G A Costa und 9 weiteren Autor:innen. Beteiligte Einrichtung: Gonçalo Moniz Institute, Oswaldo Cruz Foundation (IGM-FIOCRUZ/BA), Salvador, Bahia, Brazil. Hauptthemen laut MEDLINE: Bortezomib, Oxidative Stress, Leukemia, Myeloid, Acute, NF-kappa B. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Coordenação de Aperfeiçoamento de Pessoal de Nível Superior, Fundação Oswaldo Cruz, Conselho Nacional de Desenvolvimento Científico e Tecnológico.
Abstract (Originalsprache)
Acute myelogenous leukaemia (AML) originates and is maintained by leukaemic stem cells (LSCs) that are inherently resistant to antiproliferative therapies, indicating that a critical strategy for overcoming chemoresistance in AML therapy is to eradicate LSCs. In this work, we investigated the anti‐AML activity of bortezomib (BTZ), emphasizing its anti‐LSC potential, using KG‐1a cells, an AML cell line with stem‐like properties. BTZ presented potent cytotoxicity to both solid and haematological malignancy cells and reduced the stem‐like features of KG‐1a cells, as observed by the reduction in CD34‐ and CD123‐positive cells. A reduction in NF‐κB p65 nuclear staining was observed in BTZ‐treated KG‐1a cells, in addition to upregulation of the NF‐κB inhibitor gene NFΚBIB . BTZ‐induced DNA fragmentation, nuclear condensation, cell shrinkage and loss of transmembrane mitochondrial potential along with an increase in active caspase‐3 and cleaved PARP‐(Asp 214) level in KG‐1a cells. Furthermore, BTZ‐induced cell death was partially prevented by pretreatment with the pancaspase inhibitor Z‐VAD‐(OMe)‐FMK, indicating that BTZ induces caspase‐mediated apoptosis. BTZ also increased mitochondrial superoxide levels in KG‐1a cells, and BTZ‐induced apoptosis was partially prevented by pretreatment with the antioxidant N ‐acetylcysteine, indicating that BTZ induces oxidative stress‐mediated apoptosis in KG‐1a cells. At a dosage of 0.1 mg/kg every other day for 2 weeks, BTZ significantly reduced the percentage of hCD45‐positive cells in the bone marrow and peripheral blood of NSG mice engrafted with KG‐1a cells with tolerable toxicity. Taken together, these data indicate that the anti‐LSC potential of BTZ appears to be an important strategy for AML treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Gonçalo Moniz Institute, Oswaldo Cruz Foundation (IGM-FIOCRUZ/BA), Salvador, Bahia, Brazil.
- SENAI Institute for Innovation in Advanced Health Systems, SENAI CIMATEC, Salvador, Bahia, Brazil.
- Department of Propaedeutics, Faculty of Dentistry, Federal University of Bahia (UFBA), Salvador, Bahia, Brazil.
- Center for Biotechnology and Cell Therapy, D'Or Institute for Research and Education (IDOR), Salvador, Bahia, Brazil.
ORCID-Profile: Milena B P Soares, Clarissa Araujo Gurgel Rocha, Rosane Borges Dias, Daniel P Bezerra
Förderung
- Coordenação de Aperfeiçoamento de Pessoal de Nível Superior
- Fundação Oswaldo Cruz
- Conselho Nacional de Desenvolvimento Científico e Tecnológico
- Fundação de Amparo à Pesquisa do Estado da Bahia
Zitieren
APA
Costa, R. G. A., Oliveira, M. S., Rodrigues, A. C. B. D. C., Silva, S. L. R., Dias, I. R. S. B., Soares, M. B. P., de Faro Valverde, L., Gurgel Rocha, C. A., Dias, R. B., & Bezerra, D. P. (2024). Bortezomib suppresses acute myelogenous leukaemia stem‐like KG ‐1a cells via NF‐κB inhibition and the induction of oxidative stress. Journal of Cellular and Molecular Medicine. https://doi.org/10.1111/jcmm.18333
Vancouver
Costa RGA, Oliveira MS, Rodrigues ACBDC, Silva SLR, Dias IRSB, Soares MBP, et al. Bortezomib suppresses acute myelogenous leukaemia stem‐like KG ‐1a cells via NF‐κB inhibition and the induction of oxidative stress. Journal of Cellular and Molecular Medicine. 2024. doi:10.1111/jcmm.18333
BibTeX
@article{Costa2024,
author = {Costa, Rafaela G A and Oliveira, Maiara de S and Rodrigues, Ana Carolina B da C and Silva, Suellen L R and Dias, Ingrid R S B and Soares, Milena B P and de Faro Valverde, Ludmila and Gurgel Rocha, Clarissa Araujo and Dias, Rosane Borges and Bezerra, Daniel P},
title = {Bortezomib suppresses acute myelogenous leukaemia stem‐like KG ‐1a cells via NF‐κB inhibition and the induction of oxidative stress},
journal = {Journal of Cellular and Molecular Medicine},
year = {2024},
doi = {10.1111/jcmm.18333}
}
EUVIMED